PRPSL1L1: A Potential Drug Target and Biomarker (G221823)

Target Name: PRPS1L1

NCBI ID: G221823

PRPS1L1

PRPSL1L1: A Potential Drug Target and Biomarker

The protein encoded by the PrEP-1 gene is a glycoprotein in the human body and is mainly produced by liver, kidney and small intestinal epithelial cells. PRPSL1L1 plays a key role in maintaining liver health and is involved in glucose metabolism and drug metabolism. At the same time, it also plays an important role in antiviral and antitumor responses.

Pharmacological significance of PRPSL1L1

PRPSL1L1, as a glycoprotein, has various pharmacological significances. First, PRPSL1L1 can be used as a target of drug metabolism. The human liver is the main site of drug metabolism. Drug enzymes in liver cells can catalyze the oxidation, reduction, hydrolysis and other reactions of drugs. Liver glycoprotein PRPSL1L1, as an important component in glucose metabolism, can affect the metabolism speed and efficacy of drugs. Therefore, PRPSL1L1 can be used as a target of drug metabolism to develop drugs with better efficacy.

PRPSL1L1 can also serve as a biomarker for tumors and viral infections. Tumors and viral infections can both cause changes in liver glycoproteins, causing changes in the expression level of liver glycoprotein PRPSL1L1. Therefore, by detecting the expression level of liver glycoprotein PRPSL1L1, it can be used for the diagnosis and monitoring of tumors and viral infections.

Pharmacokinetic significance of PRPSL1L1

Pharmacokinetics is the description of the absorption, distribution, excretion and other processes of drugs in the body, and is an important link in the efficacy of drugs in the body. As a glycoprotein, PRPSL1L1 plays an important role in drug metabolism and can affect the efficacy and pharmacokinetics of drugs.

PRPSL1L1 can affect the efficacy of drugs. The efficacy of a drug is related to its concentration in the body, and the liver glycoprotein PRPSL1L1 can affect the concentration of the drug in the body. For example, some drugs are metabolized in the liver. The higher the content of liver glycoprotein PRPSL1L1, the higher the concentration of the drug in the body, thereby enhancing the drug's efficacy.

PRPSL1L1 can affect the pharmacokinetics of drugs. Pharmacokinetics of drugs mainly describes the absorption, distribution and excretion processes of drugs in the body. Liver glycoprotein PRPSL1L1 can affect the absorption, distribution and excretion process of drugs in the body, thereby affecting the pharmacokinetics of drugs.

Application of PRPSL1L1 in drug development

As a glycoprotein, PRPSL1L1 has important application value in drug research and development. First, PRPSL1L1 can be used as a target of drug metabolism to develop drugs with better efficacy. For example, the use of liver glycoprotein PRPSL1L1 can influence the characteristics of drug metabolism and develop more effective anti-tumor drugs.

Secondly, PRPSL1L1 can also be used as a biomarker of tumors and viral infections for the diagnosis and monitoring of tumors and viral infections. For example, by detecting the expression level of liver glycoprotein PRPSL1L1, it can be used for early diagnosis and prognosis assessment of tumors and viral infections.

Protein Name: Phosphoribosyl Pyrophosphate Synthetase 1 Like 1

Functions: Catalyzes the synthesis of phosphoribosylpyrophosphate (PRPP) that is essential for nucleotide synthesis

The "PRPS1L1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRPS1L1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets